Security key
05280R100
Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL)
CUSIP: 05280R100
Q1 2024 13F Holders as of 31 Mar 2024
- Type / Class
- Equity / Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share
- Shares outstanding
- 266,837,198
- Total 13F shares
- 175,580,707
- Share change
- +59,627,337
- Total reported value
- $1,120,176,501
- Put/Call ratio
- 42%
- Price per share
- $6.38
- Number of holders
- 114
- Value change
- +$380,385,653
- Number of buys
- 70
- Number of sells
- 31
Report period
Q1 2024
Institutions
114
Top holders
10
AUTL full security history
Newer quarter: Q2 2024
Previous quarter: Q4 2023
Autolus Therapeutics plc SEC filings
Autolus Therapeutics plc company facts
Broader feeds
Reporting periods
Holder history for CUSIP 05280R100
Recent filing periods:
Top shareholders of AUTL - Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Syncona Portfolio Ltd |
13F
|
Company |
8%
|
21,346,829
|
$137,473,579 | — | 31 Dec 2023 | |
| Blackstone Inc. |
13F
|
Company |
7.7%
|
20,485,611
|
$131,927,335 | — | 31 Dec 2023 | |
| Paradigm Biocapital Advisors LP |
13F
|
Company |
4.7%
|
12,611,335
|
$81,216,997 | — | 31 Dec 2023 | |
| Deep Track Capital, LP |
13F
|
Company |
4.4%
|
11,869,297
|
$76,438,273 | — | 31 Dec 2023 | |
| Tetragon Partners GP Ltd |
13F
|
Company |
3%
|
8,000,000
|
$51,520,000 | — | 31 Dec 2023 | |
| Cormorant Asset Management, LP |
13F
|
Company |
2%
|
5,450,000
|
$35,098,000 | — | 31 Dec 2023 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
1.4%
|
3,850,000
|
$24,794,000 | — | 31 Dec 2023 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.4%
|
3,825,532
|
$24,636,426 | — | 31 Dec 2023 | |
| Frazier Life Sciences Management, L.P. |
13F
|
Company |
1.4%
|
3,746,857
|
$24,129,759 | — | 31 Dec 2023 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
1.1%
|
3,001,208
|
$19,328,000 | — | 31 Dec 2023 | |
| Perpetual Ltd |
13F
|
Company |
0.77%
|
2,064,731
|
$13,296,868 | — | 31 Dec 2023 | |
| Lynx1 Capital Management LP |
13F
|
Company |
0.7%
|
1,858,409
|
$11,968,154 | — | 31 Dec 2023 | |
| PERCEPTIVE ADVISORS LLC |
13F
|
Company |
0.69%
|
1,831,167
|
$11,792,715 | — | 31 Dec 2023 | |
| SCHRODER INVESTMENT MANAGEMENT GROUP |
13F
|
Company |
0.63%
|
1,672,732
|
$10,772,394 | — | 31 Dec 2023 | |
| Affinity Asset Advisors, LLC |
13F
|
Company |
0.58%
|
1,550,408
|
$9,984,628 | — | 31 Dec 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.51%
|
1,355,339
|
$8,728,383 | — | 31 Dec 2023 | |
| FRED ALGER MANAGEMENT, LLC |
13F
|
Company |
0.51%
|
1,354,331
|
$8,721,892 | — | 31 Dec 2023 | |
| Laurion Capital Management LP |
13F
|
Company |
0.33%
|
885,471
|
$5,702,433 | — | 31 Dec 2023 | |
| Walleye Capital LLC |
13F
|
Company |
0.32%
|
850,151
|
$5,474,972 | — | 31 Dec 2023 | |
| Alphabet Inc. |
13F
|
Company |
0.26%
|
698,262
|
$4,496,807 | — | 31 Dec 2023 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
0.21%
|
560,252
|
$3,608,022 | — | 31 Dec 2023 | |
| LGT CAPITAL PARTNERS LTD. |
13F
|
Company |
0.21%
|
550,000
|
$3,542,000 | — | 31 Dec 2023 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
0.2%
|
538,766
|
$3,469,653 | — | 31 Dec 2023 | |
| MARSHALL WACE, LLP |
13F
|
Company |
0.19%
|
496,953
|
$3,200,377 | — | 31 Dec 2023 | |
| STEMPOINT CAPITAL LP |
13F
|
Company |
0.17%
|
451,375
|
$2,906,855 | — | 31 Dec 2023 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.15%
|
407,450
|
$2,623,978 | — | 31 Dec 2023 | |
| MAI Capital Management |
13F
|
Company |
0.13%
|
351,906
|
$2,266,275 | — | 31 Dec 2023 | |
| HARBOR CAPITAL ADVISORS, INC. |
13F
|
Company |
0.12%
|
308,502
|
$1,986,753 | — | 31 Dec 2023 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.1%
|
262,694
|
$1,691,750 | — | 31 Dec 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.1%
|
257,256
|
$1,656,729 | — | 31 Dec 2023 | |
| ExodusPoint Capital Management, LP |
13F
|
Company |
0.09%
|
251,361
|
$1,619,000 | — | 31 Dec 2023 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.08%
|
221,489
|
$1,426,389 | — | 31 Dec 2023 | |
| Erste Asset Management GmbH |
13F
|
Company |
0.07%
|
195,000
|
$1,292,850 | — | 31 Dec 2023 | |
| DAFNA Capital Management LLC |
13F
|
Company |
0.07%
|
191,070
|
$1,230,491 | — | 31 Dec 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.06%
|
159,600
|
$1,028,000 | — | 31 Dec 2023 | |
| Jump Financial, LLC |
13F
|
Company |
0.06%
|
154,164
|
$992,816 | — | 31 Dec 2023 | |
| TD ASSET MANAGEMENT INC |
13F
|
Company |
0.05%
|
135,300
|
$871,332 | — | 31 Dec 2023 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.05%
|
131,731
|
$848,348 | — | 31 Dec 2023 | |
| Cetera Investment Advisers |
13F
|
Company |
0.05%
|
131,500
|
$846,860 | — | 31 Dec 2023 | |
| VICTORY CAPITAL MANAGEMENT INC |
13F
|
Company |
0.04%
|
119,230
|
$767,841 | — | 31 Dec 2023 | |
| Global IMC LLC |
13F
|
Company |
0.04%
|
118,721
|
$764,563 | — | 31 Dec 2023 | |
| Atle Fund Management AB |
13F
|
Company |
0.04%
|
96,345
|
$620,462 | — | 31 Dec 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
86,256
|
$555,488 | — | 31 Dec 2023 | |
| UBS Group AG |
13F
|
Company |
0.03%
|
84,655
|
$545,178 | — | 31 Dec 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0.03%
|
81,369
|
$524,016 | — | 31 Dec 2023 | |
| Rathbones Group PLC |
13F
|
Company |
0.03%
|
69,300
|
$446,292 | — | 31 Dec 2023 | |
| JANE STREET GROUP, LLC |
13F
|
Company |
0.03%
|
67,495
|
$434,668 | — | 31 Dec 2023 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
0.02%
|
65,527
|
$421,994 | — | 31 Dec 2023 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.02%
|
60,730
|
$391,101 | — | 31 Dec 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.02%
|
53,004
|
$341,346 | — | 31 Dec 2023 |
Institutional Holders of Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL) as of Q1 2024
As of 31 Mar 2024,
Autolus Therapeutics plc - Ordinary Shares, nominal value $0.000042 per share, and American Depositary Shares ("ADS"). Each ADS represents one Ordinary Share (AUTL) was held by
114 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
175,580,707 shares.
The largest 10 holders included
Syncona Portfolio Ltd, Blackstone Inc., Deep Track Capital, LP, Avoro Capital Advisors LLC, WELLINGTON MANAGEMENT GROUP LLP, FMR LLC, TFG Asset Management GP Ltd, Cormorant Asset Management, LP, Paradigm Biocapital Advisors LP, and PRICE T ROWE ASSOCIATES INC /MD/.
This page lists
116
institutional shareholders reporting positions in this security
for the Q1 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q1 2024 vs Q4 2023 Across Filers
Q4 2023 holders
97
Q1 2024 holders
114
Holder diff
17
| Investor | Q4 2023 Shares | Q1 2024 Shares | Share Diff | Share Chg % | Q4 2023 Value $ | Q1 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.